^
    Contact us  to learn more about
    our Premium Content:  News alerts, weekly reports and conference planners
    DRUG:

    SCRI-CARB7H3(s)x19

    i
    Other names: SCRI-CARB7H3(s)x19 , Autologous CD4+ and CD8+ T-cells genetically modified to a bispecific B7H3xCD19 CAR, bispecific B7H3xCD19 CAR, second generation 4-1BBζ B7H3-EGFRt-DHFR(selected) and a second generation 4-1BBζ CD19-Her2tG
    Associations
    News
    Trials
    Company:
    Seattle Children's Hospital
    Drug class:
    CD19-targeted CAR-T immunotherapy, HER2-targeted CAR-T immunotherapy, B7-H3-targeted CAR-T immunotherapy
    Related drugs:
    Associations
    News
    Trials